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ABSTRACT 
Background:  Peanut allergy (PA) is known to impact on quality of life (QoL) of the 
sufferer, but little research has focused on all family members.  We therefore sought 
to establish the impact of PA on QoL and reported anxiety of children with clinically 
confirmed PA, their parents and older siblings. 
Methods:  46 families, who had a child with PA, completed QoL, (PedsQLTM or 
WHOQOL-BREF), anxiety (SCAS or STAI) and perceived stress (PSS) scales.  PA 
children completed a PA specific QoL questionnaire (Avery, 2003).  Parents and 
sibling also completed QoL proxy questionnaires for the PA child (PedsQLTM, Avery 
2003). 
Results:  Mothers rated their own psychological (p<0.01) and physical (p<0.05) QoL 
significantly worse than fathers rated theirs, and had higher scores than fathers for 
anxiety (p<0.05) and stress (p<0.001).  Children with PA had significantly poorer 
physical health related QoL (p<0.05), QoL within school (p<0.01) and general QoL 
(p<0.05) than their siblings did and greater separation anxiety (p<0.05).  The majority 
of differences were between girls with PA and female siblings.  Mothers felt that there 
was a greater impact on QoL for their PA child, compared with that reported by 
siblings, fathers or the PA children themselves (p<0.01).  
Conclusions:  Mothers report that they have significantly poorer QoL and suffer more 
anxiety and stress than fathers do; this inter-parental difference may be an important 
feature of family stress caused by PA.  Siblings have a similar view of how QoL 
affects the PA child as the PA child does, while mothers may possibly overestimate 
this impact. 
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Introduction  
Food allergy affects around 6% of school children (1,2) and can have severe 
consequences, including fatal anaphylactic reactions (3). Current treatment focuses on 
prevention of anaphylaxis by avoidance of trigger foods.  When accidental ingestion 
does occur the symptoms may be acute and severe and require emergency treatment.  
Food allergy can therefore have a significant impact on psychosocial aspects of 
quality of life (QoL) (4), extending beyond the immediate clinical effects of the 
patient’s allergic condition.  For example dietary restrictions may compromise social 
activities such as dining out or attending social functions and necessitate careful 
reading of food labels (5) and the daily activities of families caring for a child with 
food allergy can be affected (6). 
 
Sicherer et al (7) found that food allergy in children had a significant impact on 
parental perception of general health, emotional impact on the parent and subsequent 
limitation of family activities, using a children’s health questionnaire to look at health 
related QoL.  However, other areas of QoL such as environment or social welfare 
were not investigated and 93% of the parents completing the questionnaire were 
mothers of the allergic child and so father’s perspectives were not fully considered.  
Primeau et al (8) showed that families of children with peanut allergy experienced 
significantly more disruption in familial and social interactions than families of a 
child with chronic rheumatological disease. They suggested this may be due to the 
constant fear of sudden death from anaphylactic reaction in the peanut allergic group, 
leading to parental restriction of activities.  Again only adults were asked to complete 
the questionnaires and it is questionable whether rheumatological disease is a suitable 
comparison group for peanut allergy in both its symptomatology and management. 
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The only study that has investigated QoL from a food allergic child’s perspective 
asked children with peanut allergy and children with insulin dependent diabetes 
mellitus (IDDM) to report their own QoL using a questionnaire specifically developed 
for the study.  In this study children with peanut allergy reported poorer QoL than 
children with IDDM, and they described more fear and anxiety about managing their 
allergy than the IDDM group did about managing their diabetes (9).  
 
The primary aim of the present study was to investigate the impact on QoL and 
anxiety reported by a child with peanut allergy and by their immediate family 
members.  There is evidence in the literature that proxy ratings of parents and teachers 
of variables such as depression, anxiety, well-being and emotional and social health-
related quality of life are different to the ratings of the children themselves 
(10,11,12,13) although no studies have examined differences in sibling ratings.  This 
study therefore also sought to measure the differences in the perception of QoL 
between both parents and older sibling of the child with peanut allergy compared to 
the child with peanut allergy’s own perceptions, using validated QoL scales. 
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Methods 
Design 
This was a cross-sectional questionnaire study, measuring quality of life, anxiety and 
stress. The study gained ethical approval from Southampton and South West 
Hampshire Local Research Ethics Committee (LREC number 04/Q1701/53).   
 
Participants 
Each family included in the study had to have a child with clinically confirmed peanut 
allergy (PA) age 8-12, at least one older sibling (15 years and under), living in the 
family home with no personal history of food allergy or intolerance, and both 
biological parents living at home, with no personal history of food allergy or 
intolerance.  All family members included in the study had to be living in the family 
home in order for there to be parity in completion of proxy quality of life measures.  
No allergy or intolerance in other family members ensured that this would not affect 
scores on measured variables. 
 
The diagnosis of PA was made by a pediatric allergy consultant using similar criteria 
to Fleischer et al (14).  All PA children had to have a history of exposure to peanut 
resulting in typical acute allergic symptoms (participants who had never knowingly 
reacted to peanut were excluded) and positive skin prick test (SPT) or specific 
Immunoglobulin E (SpIgE).  The most common peanut-induced symptoms were 
angioedema (reported by 43% of children), followed by difficulty breathing (39%), 
urticaria (37%) and nausea or vomiting (24%). 
 
All children (apart from one who had SpIgE measured only) had SPT results ranging 
from 6mm to17mm wheals (average 8mm).  In 20 cases blood was also taken for 
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SpIgE, resulting in ranges from 0.38 to >100UA/L; four children also had positive 
food challenges.  Given these results there is a very high likelihood of reactivity in 
these children (15,16). 
 
All children with PA were avoiding peanut at the time of the study and had been 
prescribed oral antihistamine for mild to moderate allergic reactions and self-
administered intramuscular epinephrine for anaphylaxis.  All families had instruction 
on recognition and management of allergic reactions and the use of self-administered 
epinephrine from one experienced allergy nurse (RMK). 
 
Materials 
State-Trait Anxiety Inventory (STAI) (17) is a 40-item self-report measure split into 
two sections of 20 questions scored 1-4, which measure state (how you feel generally) 
and trait (how you feel right now) anxiety. The higher the score on the STAI the 
higher the level of anxiety (minimum score 20; maximum 80 for each section).  Mean 
normative scores for a healthy adult U.S. population are shown in Table 1.  There is 
excellent internal consistency for the state and trait anxiety sections of the scale 
(Cronbach’s α > .90, > .89 respectively) (17). 
 
Perceived Stress Scale - 14 (PSS-14) (18) is a 14-item self-report measure which asks 
about thoughts and feelings in the last month and includes items such as ‘In the last 
month, how often have you dealt with irritating life hassles?’  Items are measured on a 
Likert scale scoring 0 (never) to 4 (always) with a higher score indicating greater 
perceived stress.  Cohen and Williamson (19) have suggested that in an adult healthy 
U.S. population scores range between 0 and 45, with a mean of 19.62 (Table 1).  This 
measure has good internal consistency (Cronbach’s α = .84) (19). 
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The World Health Organisation QoL Scale (Brief version) (WHOQOL-BREF) (20) is 
a 26 item QoL scale, using a 1 to 5 Likert scale, which measures four major domains: 
physical, psychological, social relationships and environment.   Raw scores are 
computed into transformed scores with a range of 4 to 20.  There are also two one-
item questions, which look at overall quality of life and satisfaction with health and 
have a score range of 1 to 5 on each.  A higher score on this scale relates to better 
quality of life.  The scale has good reliability for physical health, environmental and 
psychological domains (alphas range from 0.80 to 0.82) but only marginally good for 
the social relationships domain (0.68).  Norm data for a U.K. adult healthy population 
adjusted for age and sex (20) are reported in Table 1. 
 
Pediatric QoL Inventory 4.0 (PedsQLTM) (21) is a 23-item self-report generic quality 
of life scale with developmentally appropriate self-report forms for children (age 8 to 
12) and adolescents (age 13 to 18), and proxy-report forms for parents.  It is designed 
for use in the community, school and clinical paediatric populations and with healthy 
children or those with acute or chronic disorders.  The PedsQLTM 4.0  measures 
physical, emotional, social and school functioning and provides a total scale score, a 
physical health summary score and a psychosocial health summary score, with 
children rating on a five-point Likert scale (never, almost never, sometimes, often, 
almost always) how often they experience things.  Each sub-scale and composite scale 
is marked out of 100 and higher scores represent a better quality of life.  All scales 
have good reliability for the total scale score, with alphas over 0.85 for the self and 
proxy versions and the scale has been validated against children with asthma (22) and 
diabetes (23).  Norm data for 699 healthy U.S. children aged 5-16 years (24) are 
reported in Table 2. 
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The QoL questionnaire for children with PA (9) is an unvalidated 25 item self-report 
measure, developed for children aged 8 and over.  Children are asked to rate how 
often things happen to them using a Likert scale, ranging from never (scored 1) to 
always (scored 4); scores range from 25 to 100 with a higher score indicating a poorer 
QoL.  It includes items such as ‘people treat me differently because of my peanut 
allergy’ and ‘I worry about going to school because of my peanut allergy’.  For this 
sample the scale demonstrated good internal consistency with alpha of 0.78 for the 
self-administered version and 0.75-0.79 for the proxy versions. 
 
Spence Child Anxiety Scale (SCAS) (25) is a self-report scale which has been 
developed specifically for children aged 8 upwards and consists of 38 anxiety items.  
It provides an overall measure of anxiety together with six sub-scale scores measuring 
panic attack and agoraphobia, separation anxiety, physical injury fears, social phobia, 
obsessive compulsive, generalised anxiety disorder/overanxious disorder; higher 
scores represent greater anxiety.  Children rate on a four-point Likert scale – never, 
sometimes, often or always – how often something happens to them.  The scale has 
high internal reliability with an alpha of 0.92 and a Guttman split-half reliability of 
0.90.  Test-retest reliability was 0.51 on children tested after 6 months.  Norm data 
based on a sample of 2,052 healthy Australian children age 8-12 (26) are reported in 
Table 2. 
 
Procedure 
Families were recruited from the paediatric allergy clinic at Southampton University 
Hospital, UK.  Informed written consent was obtained from each family member 
participating in the study.  The questionnaires with instructions on how to complete 
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them were sent home via the attending child and parent, with a stamped addressed 
envelope for their return.  The PA child was asked to complete the peanut food allergy 
quality of life questionnaire (9), the PedsQLTM and the SCAS.  The sibling was asked 
to complete the PedsQLTM and the SCAS for themselves and the Avery scale and 
PedsQLTM as a proxy measure for the PA child.  Parents were asked to complete the 
STAI, the PSS and the WHOQOL-BREF for themselves and the Avery scale and 
PedsQLTM as a proxy measure for the PA child.  Parents were specifically directed not 
to help children complete the questionnaires but to let them fill in the questionnaires 
on their own and not influence the answers from the children.  Data was collected 
between August 2004 and July 2006. 
 
Data analysis 
Statistical analyses were conducted using SPSS for Windows, (version 14, SPSS, 
Illinois, USA).   Differences between parents, siblings and the children with PA were 
analysed using paired samples or independents samples t-tests and MANOVA where 
appropriate.  Repeated measures ANOVA was conducted on measures that were 
directly comparable (the generic quality of life scale and the food allergy specific 
quality of life scale) in order to analyse differences between scores within each family 
unit.  All tests carried out were 2-tailed and significance level was set at p<0.05.  Post 
hoc power calculations showed the study to have 0.7 power to detect medium to large 
effect sizes between two groups and 0.8 power to detect medium to large effect sizes 
between four groups.   
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Results  
Fifty-six families were approached to take part and 46 families completed all 
questionnaires (a response rate of 82%). Of those who took part 35% of PA children 
were girls (n = 16, mean age 10 years, s.d. = 1.6) and 65% were boys (n = 30, mean 
age 9.6 years, s.d. = 1.3).  For the siblings 63% were girls (n = 29, mean age 12.8 
years, s.d. 1.5) and 37% were boys (n =17, mean age 13 years, s.d. 1.2).   Fathers’ 
mean age was 45.33 years (s.d. = 4.42) and mothers’ was 42.59 years (s.d. = 4.46); 
57% of both mothers and fathers had been educated to tertiary level, 41% had been 
educated to secondary level. 
 
66.7% (n=30) of PA children reported other food allergies including tree nut allergy 
(n=24); egg (n=9); fruits (n=6); legumes (n=3) and wheat or soy (n=2).  80% (n=36) 
of PA children had other atopic conditions (69.5% asthma; 54.3% eczema; 47.8% hay 
fever).  15.6% (n=7) reported having to use their Epi-Pen in an emergency and 40% 
(n=18) had been admitted to an accident and emergency department due to a food-
induced reaction. 
 
Parental Ratings 
Mothers scored significantly higher than fathers on state anxiety (t(89)=-2.13, 
p=0.04), trait anxiety (t(88)=-3.33, p=0.001) and perceived stress (t(89)=-4.23, 
p<0.001).  Mothers’ trait anxiety (t(45)=3.52, p<0.001) and stress (t(45)=5.60, 
p<0.001) were also significantly higher than norm means, while fathers’ state anxiety 
was significantly lower (t(44)=-2.26, p<0.05).  Mothers rated their psychological QoL 
(t(90)=3.16, p=0.002) and physical QoL (t(90)=2.08, p=0.04) as significantly worse 
than fathers (see Table 1).  However, mothers and fathers reported significantly better 
quality of life than the norm means for all quality of life sub-scales (apart from 
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psychological quality of life in mothers, where there was no significant difference) 
(Table 1). 
 
Comparisons between all children with PA and their siblings 
Children’s anxiety scores were significantly lower than published norms on all 
subscales apart from separation anxiety and physical injury for children with PA, 
where there was no significant difference.  However, children with PA did rate 
separation anxiety as significantly higher than their siblings (t(85)=2.39, p=0.02) 
(Table 2).  
 
Children with PA had poorer emotional QoL (t(44)=-2.11, p<0.05) and psychosocial 
health (t(44)=-2.05, p<0.05) than the norm means.  They also rated physical health 
related QoL (t(87)=-2.31, p=0.02), QoL within school (t(87)=-2.64, p=0.01) and total 
QoL (t(87)=-2.02, p=0.05) as significantly poorer than their siblings (Table 2).  
Siblings however reported better physical health related QoL (t(43)=5.59, p<0.001), 
QoL within school (t(43)=2.09, p<0.05) and overall QoL (t(43)=2.03, p<0.05) than 
the norm means (Table 2). 
 
Comparisons between girls and boys with PA 
Girls with PA had significantly higher scores for anxiety over physical injury than 
boys with PA (t(43)=-3.76, p=0.001) (Table 3).  There were no other significant 
differences for anxiety or quality of life. 
 
Comparisons between girls with PA and female siblings 
Girls with PA had significantly higher scores for separation anxiety (t(39)=2.35, 
p=0.02) and anxiety over physical injury, than female siblings (t(39)=2.10, p<0.05).  
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They also rated QoL in school (t(40), -1.96, p=0.05), physical health related QoL 
(t(40), -2.36, p=0.02) and total quality of life as significantly worse than female 
siblings (t(45), -2.09, p<0.05), (Table 3). 
 
Comparisons between boys with PA and male siblings 
There were no significant differences in anxiety ratings between boys with PA and 
male siblings, but boys with PA did rate QoL in school as significantly worse than 
male siblings (t(45), -2.05, p<0.05) (Table 3). 
 
Comparisons on allergy-related parameters 
There were no significant differences in anxiety or QoL ratings for PA children who 
had multiple food allergies compared to those who only had peanut allergy; nor were 
there any significant differences for those who had been admitted to an accident and 
emergency department or not.  PA children who reported having to use their Epi-Pen 
in an emergency did have significantly poorer health-related quality of life 
(mean=75.90, s.d.=16.10) compared to those had not used their Epi-pen (mean=88.23, 
s.d.=13.20), t(43)=-2.20, p<0.05 and poorer emotional quality of life (mean=65.00, 
s.d.=17.32) than those who had not used their Epi-Pen (mean=78.16, s.d.=14.68), 
t(43)=-2.12, p<0.05.  PA children who had other atopic conditions did not have 
significantly different anxiety ratings to those who had no other atopic conditions, but 
they did report poorer QoL on all of the PedsQLTM sub-scales apart from school-
related QoL (F(1,43)=6.807, p<0.01) (Table 4). 
 
Siblings of PA children with multiple food allergies reported greater general anxiety 
(mean=5.11, s.d.=3.47) than siblings of PA children with only peanut allergy 
(mean=2.64, s.d.=2.41), t(40)=2.38, p<0.05.  There were no differences in anxiety, 
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stress or QoL ratings of parents of children with multiple food allergies or other atopic 
conditions compared to parents of children with peanut allergy only, or those with no 
other atopic conditions.  Nor were there any differences in ratings of parents of 
children who had used their Epi-pen in an emergency or not.  However, mothers of 
children who had been admitted to an accident or emergency department reported 
significantly higher state anxiety (mean=38.83, s.d.=11.29) than those who had not 
been admitted (mean=31.92, s.d.=8.57), t(44)=2.35, p<0.05. 
 
Self and proxy-ratings differences 
A MANOVA was conducted to compare self and proxy quality of life scores for the 
peanut allergic child on the scale developed by Avery et al. (9) and the PedsQLTM 
sub-scales, however, no significant differences were found (F=1.49, p=0.076 using 
Pillai’s Trace statistic).  MANOVA only compares across groups (i.e. PA child, 
sibling, mother and father), therefore repeated measures ANOVAs were conducted to 
compare scores within family units for the directly comparable quality of life 
measures.  For the peanut allergy specific quality of life scale, mothers rated their 
child with PA’s QoL significantly worse (mean=54.54, s.d.=7.44) than the child’s 
own ratings (51.07, s.d.=7.48) and the proxy ratings of the sibling (mean=50.73, 
s.d.=7.17) and father (mean=51.27, s.d.=7.43), (F(3,120)=4.07, p=0.009).           
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There was one significant difference between the self and proxy scores for the generic 
QoL scale; children with PA and their siblings rated the child with PA’s emotional 
QoL as significantly better (child with PA mean =75.71; sibling mean = 77.77) than 
the mother (mean =68.57) or father (mean =71.43), (F(3.123)=4.07, p=0.006). 
 
Discussion 
We assessed quality of life, anxiety and stress in families with a peanut allergic child, 
and examined whether family members had a similar view of the impact of peanut 
allergy on the quality of life of the peanut allergic child.  Mothers reported greater 
anxiety and stress than fathers did and their trait anxiety and perceived stress levels 
were significantly higher than reported norm mean values for these scales, while 
fathers’ scores were more in line with or lower than norm scores (17,19).  The mother 
traditionally has a greater role in buying and preparing food and so greater stress and 
anxiety may be caused by mothers taking more responsibility for reading food labels 
and making the decisions regarding what food is safe for her child to eat, which is 
often difficult due to inadequate labelling of allergenic foods (27).   
 
Mothers reported significantly poorer psychological and physical quality of life than 
fathers, however in general both parents reported better quality of life than the norm 
scores of a healthy U.K. population (20).   It may be that peanut allergy does not have 
a large impact on generic (as opposed to peanut-allergy specific) quality of life in 
parents.  Families with a child with food allergy have been found to have greater 
family cohesion (7,28) and have reported receiving significant support from spouses 
and the extended family (29), which may also partially account for the better QoL 
scores. 
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The parental differences in stress, anxiety and quality of life reported in the present 
study support the findings of previous research of parents of children with other 
chronic illnesses such as asthma and diabetes.  Poorer well-being, general health, 
quality of life and higher levels of depression and post-traumatic stress disorder have 
all been found in mothers compared to fathers (30,31,32).    Thus our findings add to 
the growing literature supporting a gender difference in the parental impact of child 
chronic illness.  The difference between the perceived impact from mothers and 
fathers may lead to greater family tension and eventually poorer health outcomes for 
all family members and should be taken into account by health care professionals.  
Divorce rates are higher in parents of children with a chronic illness or disability, 
compared to those with healthy children (33).  Therefore marital distress arising from 
differences in perceptions concerning food allergy must be addressed, possibly with 
the aid of an integrated family therapy approach which has been suggested to be 
helpful for parents with chronically ill children (34).  
 
Peanut allergic children’s generic quality of life scores were generally poorer than 
healthy children’s norms for this scale, whereas siblings generally reported better 
quality of life than the norm scores (24).  PA children with other atopic conditions 
also reported poorer QoL than PA children with no other atopic conditions.  The 
impact of peanut allergy on general health-related quality of life has been reported 
elsewhere; however in previous studies the parents have been asked to assess the 
impact on quality of life experienced by their allergic child (7,8,28).  The present 
study has demonstrated a similar impact when asking the allergic children directly.  
For anxiety both the peanut allergic child and the siblings rated their anxiety levels as 
significantly lower than most of the norm means for healthy children for this scale 
(26).  Thus, peanut allergy may not be significantly adversely affecting general 
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anxiety levels in these children.  However, the norm data are over ten years old and 
unfortunately not based on U.K. children and it is unclear how far they can be 
generalised to children in this study. 
 
Encouragingly, few significant differences between peanut allergic children and 
siblings were found in this study.  Children with peanut allergy did report greater 
separation anxiety than their siblings, possibly arising from a fear of having to 
manage their food allergy by themselves with no family help.  It is important that 
children with peanut allergy develop self-care behaviours and take more responsibility 
for their own allergy risk assessments as they grow up (35), especially in adolescence, 
a time when children are most at risk of having anaphylactic reactions after accidental 
exposure to food allergens (3,36,37,38).  Fostering these behaviours in younger 
children while counselling mothers regarding ways in which they could do this may 
help reduce anxiety levels.  Children with food allergy also reported greater impact on 
school related quality of life than their siblings.  Again, managing their food allergy 
away from the care of the family home may be a contributory factor.  Having to carry 
medication and the possible isolation from not being able to eat school dinners may 
also be making children feel different from their peers, an issue that has been 
previously reported in the literature (36,39). 
 
Research on siblings of chronically ill children has rarely focused on comparisons of 
siblings with their chronically ill brother or sister (40).  When compared to 
comparison groups or normative data a meta-analysis of the psychosocial impact on 
siblings of children with a chronic illness showed a small but negative effect size (41); 
a finding at variance with the results from this study.  However, none of the studies 
included in the meta-analysis analysis had examined children with allergy.  The 
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gender differences in anxiety and quality of life found in this study have rarely been 
examined in the literature.  Indeed sex and gender in food allergy has been under-
researched in general (42).  The little research that has reported comparisons of 
gender in children with chronic illness and healthy siblings found no significant 
differences (43), yet the findings in the present study indicate that there might be a 
greater impact on girls with peanut allergy compared to female siblings, rather than 
boys with peanut allergy.  There is therefore a need to further explore the impact food 
allergy has on the different genders in siblings in relation to the allergic child and to 
control comparison groups.   
 
Analysis of differences in self and proxy ratings showed that mothers estimated the 
impact of food allergy on their peanut allergic child as more severe than the allergic 
child themselves.  These differences call into question the findings of studies that 
have relied solely on proxy measures of the impact of peanut allergy on quality of life 
of children.  It may be that this impact has been overestimated, particularly if mothers 
have predominantly completed the questionnaires.  Proxy ratings have been shown in 
studies of other childhood chronic illness to exaggerate the impact of psychological 
distress (10,11,12,13).  Nevertheless the reverse is entirely plausible; mothers may 
have a more realistic view of the true impact of peanut allergy on their allergic child 
than other family members.  Interviews with mothers of food allergic teenagers 
revealed that they considered the impact of food allergy on day-to-day life to be much 
greater than their affected children did (44).  One possible reason for this was mothers 
could vividly recall anaphylactic reactions that had occurred when their child was 
very young, whereas the teenagers themselves had no recollection of a severe 
reaction.  Although PA children in the present study are younger, this may partly 
explain differences in perceptions.  It may also explain why mothers, in the present 
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study, of children admitted to accident and emergency departments due to food-
induced reactions had higher anxiety levels.  Before these alternative explanations can 
be deciphered it is essential that future research focuses on the child’s own 
perceptions as well as that of parents in order to ensure reliable and valid measures of 
the impact on quality of life are obtained. 
 
There are a number of limitations in this study, which must be considered.  Firstly, the 
study relies on self-report measures, which are subject to social desirability; for 
example fathers may not have wanted to report high levels of anxiety and stress and 
adjusted their responses accordingly.  The extent to which this occurred in this study 
is unknown; however, the scores from fathers did span a wide range with some 
father’s scoring very highly on these measures, signified by the large standard 
deviations on this scale.  Social desirability bias may therefore be limited to only a 
small number of fathers in this study.   
 
A further limitation is the lack of availability of a validated peanut allergy specific 
quality of life scale at the time of data collection.  Differences in proxy ratings found 
using the un-validated scale therefore need to be treated with caution.  The generic 
scales used had the benefit of allowing comparisons to be made across siblings and 
between self and proxy ratings.  However, they may not be sensitive enough to assess 
the impact of peanut allergy specifically.  Validated food allergy specific QoL scales 
are therefore needed in order to ascertain the validity of the findings in this study.  
Two scales in particular (which were unavailable when this study began) would be 
extremely useful to use in a replication of this study: the Food Allergy Quality of Life 
– Parental Burden Questionnaire (FAQOL-PB) (45) and the Food Allergy Parent 
Questionnaire (FAPQ) (29).  Finally, the clinic- based nature of this patient group 
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means that only a relatively small number of families were recruited and the findings 
may not be generalisable to the non clinic-based population of allergic families.   
 
In conclusion, clinicians need to be aware of the differing affects of peanut allergy on 
the whole family.  The causes of the differences in impact on parents and on different 
genders in children require further investigation, alongside ways in which they can be 
redressed in order to ease the family burden of peanut allergy.  
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Table 1. Anxiety (STAI), stress (PSS) and quality of life (WHOQOL-BREF) mean 
scores (and standard deviations) for parents, with norm data for healthy adults 
Domain Mothers Fathers Norm Data 
 Mean (S.D.) Mean (S.D.) Mean (S.D.) 
State anxiety 34.63a (10.19) 30.42ac (8.54) 33.3c (9.5) 
Trait anxiety 39.04ab (12.04) 31.77a (8.24) 32.8b (8.3) 
Perceived stress 25.13ab (6.67) 19.62a (5.71) 19.62b (7.49) 
WHOQOL-BREF    
Overall QoL 4.30 (0.63) 4.15 (0.63) Not available 
Satisfaction with health 3.85 (0.92) 4.02 (0.71) Not available 
Physical 16.65ab (2.02) 17.46ac (1.67) 15.8bc (3.8) 
Psychological 14.61a (2.08) 15.85ac (1.66) 14.7c (3.4) 
Social 15.63b (2.33) 15.46c (2.83) 14.2bc (3.5) 
Environmental 15.85b (2.08) 16.07c (2.10) 14.1bc (2.3) 
a
 = p<0.05 for comparisons between mothers and fathers; b = p<0.05 for comparisons 
between mothers and norms; c = p<0.05 for comparisons between fathers and norms 
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Table 2.  Anxiety (SCAS) and quality of life (PedsQLTM) mean scores (and standard 
deviations) for allergic children and siblings, with norm data for healthy children 
^Obsessive Compulsive Disorder   a = p<0.05 for comparisons between children with 
PA and siblings; b = p<0.05 for comparisons between children with PA and norms; c = 
p<0.05 for comparisons between siblings and norms 
 
Domain Allergic children Siblings Norm data 
 Mean (S.D.) Mean (S.D.) Mean (S.D.) 
SCAS    
Panic 2.69b (2.65) 2.12c (3.13) 4.42bc (4.85) 
Separation anxiety 3.96a (3.23) 2.33ac (3.01) 4.90c (3.75) 
Physical injury 3.20 (2.68) 2.81c (2.32) 3.66c (2.97) 
Social phobia 4.09b (3.04) 4.45c (3.62) 6.65bc (4.07) 
OCD^ 3.40b (3.22) 3.07c (2.69) 6.09bc (3.95) 
General anxiety 4.49b (2.62) 4.29c (3.34) 6.35bc (3.76) 
Total anxiety 21.80b (13.46) 19.07c (14.94) 32.08bc (18.66) 
PedsQLTM    
Physical health 86.31a (14.22) 92.19ac (9.28) 84.37c (17.33) 
Emotions 76.11b (15.66) 76.59 (18.92) 81.04b (19.54) 
Social relationships 83.44 (16.61) 89.32 (13.45) 86.82 (17.52) 
School 74.22a (16.02) 82.95ac (15.15) 78.19c (20.70) 
Psychosocial health 77.99b (13.51) 83.08 (13.46) 82.11b (15.72) 
Overall QoL 81.05a (12.89) 86.25ac (11.32) 82.79c (15.00) 
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Table 3.  Anxiety (SCAS) and quality of life (PedsQLTM)  mean scores (and standard 
deviations) for girls and boys with PA and male and female siblings 
^Obsessive Compulsive Disorder   a = p<0.05 for comparisons between girls with PA 
and female siblings; b = p<0.01 for comparisons between girls with PA and boys with 
PA; c = p<0.05 for comparisons between boys with PA and male siblings 
Domain Girls with PA Female siblings Boys with PA Male siblings 
 Mean (S.D.) Mean (S.D.) Mean (S.D.) Mean (S.D.) 
SCAS     
Panic 2.87 (3.20) 2.65 (3.52) 2.60 (2.39) 1.25 (2.18) 
Separation anxiety 5.13a (3.74) 2.77a (2.69) 3.37 (2.83) 1.63 (3.63) 
Physical injury 5.07a b (2.91) 3.50a (1.88) 2.27b (2.03) 1.69 (2.57) 
Social phobia 3.53 (2.13) 4.65 (3.63) 4.37 (3.40) 4.13 (3.70) 
OCD^ 3.53 (3.29) 3.08 (2.59) 3.33 (3.25) 3.06 (2.93) 
General anxiety 4.80 (2.83) 5.15 (3.28) 4.33 (2.54) 2.88 (3.01) 
Total anxiety 24.93 (13.92) 21.81 (14.31) 20.23 (13.18) 14.63 (15.33) 
PedsQLTM     
Physical health 81.64a (16.16) 91.55a (10.96) 88.65 (12.81) 93.20 (5.87) 
Emotions 72.00 (10.14) 74.63 (19.06) 78.17 (17.60) 18.83 (4.57) 
Social relationships 81.67 (18.39) 90.56 (13.82) 84.33 (81.67) 87.5 (13.00) 
School 72.00a (13.60) 81.30a (15.29) 75.33c (17.22) 85.59c (14.99) 
Psychosocial health 75.43 (10.73) 82.12 (14.39) 79.27 (14.71) 84.61 (12.11) 
Overall QoL 77.37 (10.50) 85.41 (12.67) 82.90 (13.73) 87.60 (8.94) 
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Table 4.  Quality of life (PedsQLTM) mean scores (and standard deviations) for 
allergic children with and without other atopic conditions 
*p<0.05   **p<0.01   ***p<0.001 
Domain Allergic children 
with atopy 
Allergic children 
without atopy 
t-value 
 Mean (S.D.) Mean (S.D.)  
PedsQLTM    
Physical health 84.28 (14.73) 94.45 (8.38) -2.73** 
Emotions 73.75 (15.83) 85.56 (11.30) -2.10* 
Social relationships 80.28 (17.11) 96.11 (3.33) -5.17*** 
School 72.50 (16.10) 81.11 (14.52) -1.46 
Psychosocial health 75.59 (13.57) 87.59 (8.29) -2.52** 
Overall QoL 78.59 (12.81) 90.92 (7.67) -2.75** 
